MinichMacGregor Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-33
Closed -$13.5K 334
2022
Q4
$13.5K Buy
+33
New +$12.8K ﹤0.01% 379
2022
Q2
Sell
-3,715
Closed -$2.03M 85
2022
Q1
$2.03M Buy
3,715
+545
+17% +$287K 0.65% 38
2021
Q4
$2.09M Buy
3,170
+853
+37% +$535K 0.64% 37
2021
Q3
$1.44M Buy
2,317
+118
+5% +$79.3K 0.48% 43
2021
Q2
$1.39M Sell
2,199
-138
-6% -$76.2K 0.49% 38
2021
Q1
$1.14M Buy
2,337
+198
+9% +$99.2K 0.43% 43
2020
Q4
$1.07M Buy
2,139
+166
+8% +$74.3K 0.44% 42
2020
Q3
$775K Buy
1,973
+102
+5% +$37.7K 0.37% 40
2020
Q2
$617K Buy
+1,871
New +$542K 0.34% 38

Other funds holding IDXX

MinichMacGregor Wealth Management's IDXX Position: Q1 2023 in Review

MinichMacGregor Wealth Management sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 33 shares — an estimated $13.5K sold.

MinichMacGregor Wealth Management first reported a position in IDXX in Q2 2020 and held it in 9 quarters. The position peaked at $2.09M in Q4 2021. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • MinichMacGregor Wealth Management reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 33 Idexx Laboratories shares in Q1 2023, an estimated $13.5K.
  • MinichMacGregor Wealth Management first reported a position in Idexx Laboratories in Q2 2020 and held it in 9 quarters.
  • MinichMacGregor Wealth Management's Idexx Laboratories position peaked at $2.09M in Q4 2021.
  • 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.